Uncover the immune biomarkers underlying hepatitis B e antigen (HBeAg) seroconversion: a need for more translational study.
George K K
GK
Lau
Fu-Sheng
FS
Wang
D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006513:Hepatitis B e Antigens / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007378:Interleukins / Q000097:blood*; D008297:Male; D009705:Nucleosides / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000627:therapeutic use*; D000077712:Telbivudine; D013936:Thymidine / Q000031:analogs & derivatives; D000098546:Interleukin-21
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D007378:Interleukins; D009705:Nucleosides; D011744:Pyrimidinones; D000077712:Telbivudine; D000098546:Interleukin-21; D013936:Thymidine